If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiome Tech Regulatory News (BIOM)

  • There is currently no data for BIOM

Interim Management Statement

18 Jul 2013 07:00

RNS Number : 5720J
Biome Technologies PLC
18 July 2013
 



18 July 2013

 

Biome Technologies plc ("Biome", "the Company" or "the Group")

Interim Trading Statement

 

 

Biome Technologies plc, a leading bioplastics and RF technology business, today publishes a trading update, ahead of its interim results for the six-month period ended 30 June 2013, which are expected to be announced on 2 September 2013.

 

Trading Update

 

Total Group revenues achieved for the second quarter were £0.5m (Q1 2013: £0.4m). As previously noted, this year is anticipated to be second half weighted and the Board expects revenue growth in both divisions as the year progresses.

 

On 23 May 2013 the Board, having completed a settlement with regard to two legacy long leases on buildings in Southampton for a cash sum of £895,000, plus VAT, proposed a process of capital reduction, consolidation and sub-division of existing ordinary shares. This process was approved by Shareholders on 20 June and the consolidated shares admitted to AIM on 16 July 2013.

 

The Board is pleased to confirm that the Court approved the proposed capital reduction on 17 July 2013. This decision will allow us to complete the process, which the Board believes will provide a clearer view of the Company's financial position and rationalise the unusually large shareholder base of the Company.

 

The Group's cash position at 30 June 2013 was £3.9m (31 March 2013: £5.8m).

 

We continue to make progress with the strategy to commercialise and develop wholly owned intellectual property and our performance remains in line with the Board's expectations.

 

Bioplastics Division

 

The Q2 2013 revenues for the Bioplastics Division were £0.1m (Q1 2013: £0.2m). This division is focused on developing high margin, application led products with enhanced level of functionality. Two key projects are currently being undertaken for single use foodservice products and single use coffee capsules.

 

The first of these projects remains in the development phase with biodegradation certification now completed and composting trials underway. This project is expected to remain under development until the final quarter of 2013.

 

The second project required significant technical support in the second quarter to ensure optimisation of our customer's manufacturing performance in the USA. This project is now passing into the manufacturing phase and shipments of substantially increased tonnages for the second half are in prospect.

 

In the first quarter, the division was awarded a grant by the Government-backed Technology Strategy Board (TSB). Work on this project started in the second quarter in conjunction with the University of Warwick's Centre for Biotechnology and Biorefining and the Group has subsequently applied for a further grant to broaden this work. The result of this application is expected in the near future.

 

Stanelco RF Technologies Division

 

The Q2 revenues for the RF Division were £0.4m (Q1 2013: £0.2m). As previously reported, a number of optical fibre furnace deliveries were delayed at the end of 2012 due to some uncertainties in the Chinese fibre market. Some pick-up was evident in the second quarter and Stanelco RF has tendered for a number of significant projects for the second half but the market is yet to return to the levels seen previously.

 

Progress continues on the Durapipe project with results from time-based testing of the final pipe-work made with the Stanelco prototypes awaited. Transition to commercial production on this project is expected in the second half. Enquiry and order levels for general industrial equipment are robust and the partnership with Forsstrom continues to build.

 

-Ends-

 

For further information please contact:

 

Biome Technologies plc

Paul Mines, Chief Executive Officer

www.biometechnologiesplc.com

Tel: +44 (0) 2380 867 100

Daniel Stewart & Company plc

 

 

David Hart/James Thomas

 

www.danielstewart.co.uk

Tel: +44 (0) 20 7776 6550

 

 

First Columbus

 

Chris Crawford/Kelly Gardiner

 

www.first-columbus.com

Tel: +44 (0) 20 3002 2070

 

 

FTI Consulting

 

Oliver Winters/Latika Shah

Tel: +44 (0) 20 7831 3113

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBLGDRXDBBGXR
Date   Source Headline
27th Apr 20071:34 pmRNSResult of AGM
27th Apr 20071:32 pmRNSDirectorate Change
26th Apr 20071:42 pmRNSAnnual Information Update
13th Apr 200712:29 pmRNSDirector's Dealing
30th Mar 20071:32 pmRNSAnnual Report and Accounts
23rd Mar 20075:09 pmRNSNotifiable Interest
21st Mar 20077:03 amRNSPreliminary Results
14th Mar 20075:59 pmRNSHolding(s) in Company
26th Feb 20077:01 amRNSBoard Appointment
23rd Feb 20073:18 pmRNSHolding(s) in Company
30th Jan 20079:00 amRNSNotice of Results
18th Dec 20064:58 pmRNSTotal Voting Rights
8th Dec 200612:31 pmRNSNotifiable Interest
28th Nov 20063:32 pmRNSNotifiable Interest
17th Nov 20063:33 pmRNSNotifiable Interest
16th Nov 20069:02 amRNSNotifiable Interest
14th Nov 20064:37 pmRNSDirectorate Change
14th Nov 20064:09 pmRNSDirector/PDMR Shareholding
14th Nov 20064:03 pmRNSNotifiable Interest
14th Nov 20069:55 amRNSNotifiable Interest
10th Nov 200610:29 amRNSHolding(s) in Company
9th Nov 200611:45 amRNSNotifiable Interest
8th Nov 20063:08 pmRNSNotifiable Interest
7th Nov 20068:01 amRNSIssue of Equity
6th Nov 200612:12 pmRNSResult of EGM
3rd Nov 20064:41 pmRNSNotifiable Interest
3rd Nov 20061:17 pmRNSOpen Offer Result - Amendment
2nd Nov 20066:03 pmRNSOpen Offer Result
31st Oct 200611:54 amRNSNotifiable Interest
17th Oct 20065:54 pmRNSNotifiable Interest
17th Oct 200610:44 amRNSNotifiable Interest
16th Oct 20063:17 pmRNSNotifiable Interest
12th Oct 200612:35 pmRNSDoc re. Posting of Prospectus
11th Oct 20061:09 pmRNSNotifiable Interest
9th Oct 200611:13 amRNSProposed Placing & Open Offer
5th Oct 200610:25 amRNSFinancing Update
3rd Oct 200612:56 pmRNSStatement re. Press Comment
2nd Oct 20064:41 pmRNSSecond Price Monitoring Extn
2nd Oct 20064:35 pmRNSPrice Monitoring Extension
8th Sep 20067:01 amRNSTrading Statement
17th Aug 20067:44 amRNSTrading Statement
16th Aug 20065:52 pmRNSAdditional Listing - AMEND
14th Aug 200611:55 amRNSAdditional Listing
10th Aug 200612:25 pmRNSRe Contract
14th Jul 20067:56 amRNSInterim Results - Replacement
14th Jul 20067:00 amRNSInterim Results
2nd Jun 200611:26 amRNSNew Ord Share Placing-Amendmt
2nd Jun 20068:45 amRNSNew Ordinary Share Placing
25th May 20067:02 amRNSWrap 100 FDA approval
16th May 200610:43 amRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.